Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
A metal processor covered here would appear to justify a much higher rating, while cash flow concerns continue to cast a shadow over a once popular litigation funder. Read on here for more on these and other stories.
The news that Pfizer and Germany’s BioNTech have made progress with a Covid-19 vaccine saw stock markets soar, although not all stocks rose, with some beneficiaries of the pandemic, notably small UK biotech stocks, falling sharply, as many clearly think their glory days will soon be coming to an end.
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on James Cropper
Bonkers Bargains: poised to recover with a new CEO
Don’t be fooled by the 175 year history, this elderly business has a reputation for innovation…
Episode 36 of the Investor’s Champion Podcast
In this episode of the Investors Champion Podcast, Chris and Lee discuss intriguing investment opportunities, focusing…
More on Jubilee Metals Group
Strap yourself in for the commodity supercycle
Are we on the verge of a new commodity supercycle, including gold and silver copper and…
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
A metal processor covered here would appear to justify a much higher rating, while cash flow…
More on Manolete Partners
Improving returns | Questionable business models
A software provider whose results we assess here continues to recover from the consequences of a…
Naked Wines: stripping shareholders bare
Results and updates covered here include yet more disappointment for shareholders of online wine retailer Naked…
More on Zoo Digital
Another AIM takeover | Bonkers Bargain delights | Profit warnings
We cover yet another takeover of a fast-growing AIM company, this time at a big premium to…
Bonkers Bargains are looking good
Results and updates covered here include impressive news from two of our Bonkers Bargain opportunities, one…
